Equity Research Capital Markets

Should You Buy Morgan Stanley Stock in 2026?

By CirclFi Research Team · · 12/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Morgan Stanley (MS) occupies a solid middle-ground position with a Quality of Company score of 7.1/10. At the current market price of $215.50, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.

The short answer: 3 of 12 CirclFi valuation models project upside for Morgan Stanley (MS) at $215.50 — the model consensus leans bearish, with a Quality Score of 7.1/10 and Value-Trap risk of 38/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 9 of 12 models suggest overvaluation — majority bearish
  • Quality Score: 7.1/10 — Strong — above-average quality
  • Value Trap Risk: 38/100 — Low — manageable risk
  • Fair Value Range: $8.36 – $440.36 (5169% spread)

Bullish Models

3 / 12

Bearish Models

9 / 12

Quality Score

7.1 /10

Strong — above-average quality

Value Trap Risk

38 /100
Low

Low — manageable risk

Model Consensus

12 /13
Active Models

Avg. confidence: 38%

Investment Thesis

The Bull Case

Target: $440.36 (+104.3% upside)

  • According to the CirclFi Quality of Company (QOC) framework, Morgan Stanley's score of 7.1/10 reflects durable competitive advantages that should sustain earnings power through market cycles.
  • According to the CirclFi Deep Alpha Valuation Engine, the Markov DDM model targets a fair value of $440.36 (+104.3%), anchoring the bull case with a methodology that provides a differentiated analytical lens.
  • Industry tailwind: fee income diversification could provide meaningful support for Morgan Stanley's revenue and margin trajectory in the Capital Markets space.
  • Scale advantage: as a $338.8B mega-cap leader, Morgan Stanley benefits from economies of scale, institutional investor demand, and index inclusion that smaller competitors lack.

The Bear Case

Target: $8.36 (-96.1%)

  • According to the CirclFi Deep Alpha Valuation Engine, the Bayesian DCF model sees the stock as overvalued with a fair value of $8.36 (-96.1%), suggesting that the market price embeds overly optimistic growth assumptions.
  • According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +200.5% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology.
  • Industry headwind: regulatory capital requirements represents a meaningful risk for Morgan Stanley and its Capital Markets peers.

Peer Benchmarking

FUTU Futu Holdings Limite
10.0
TW Tradeweb Markets Inc
10.0
SIEB Siebert Financial Co
9.7
HLI Houlihan Lokey, Inc.
9.5
PJT PJT Partners Inc.
9.4

See full Capital Markets rankings →

Valuation Divergence

Spread

5169%

Fair Value Range

$8.36 – $440.36

A 5169% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

Markov DDM

$440.36 (+104.3%)

Most Bearish

Bayesian DCF

$8.36 (-96.1%)

Key Risk Factors

Model Disagreement

5169% spread signals high variance in projections.

Bearish Consensus

9/12 models suggest overvaluation.

Macro/Sector Risk

Capital Markets headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View MS Data Page →

The Bottom Line

Caution dominates our read on Morgan Stanley at $215.50. 8 of 12 models see limited upside or outright downside, with the composite fair value at $163.02 (-24.4%). Quality at 7.1/10 provides some fundamental cushion. Current holders should re-evaluate their thesis; new buyers should demand a wider margin of safety.

These are quantitative model outputs, not investment recommendations. Morgan Stanley's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

Frequently Asked Questions

Should I buy MS stock right now?

Based on CirclFi's multi-model analysis, 3 of 12 models see upside for MS at $215.50. The models are divided, which means the investment case depends heavily on your assumptions about Morgan Stanley's future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Morgan Stanley?

Key risks include: wide model disagreement (5169% spread), signaling high uncertainty; general market and sector-specific risks affecting Capital Markets companies. Always diversify and consult a financial advisor.

How does MS compare to its competitors?

Among Capital Markets peers, MS holds a Quality Score of 7.1/10. Comparable companies include FUTU (QOC 10.0), TW (QOC 10.0), SIEB (QOC 9.7). The relative ranking helps investors identify whether MS offers better fundamental quality than alternatives in the same sector.

Is MS a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. MS's Quality Score of 7.1/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy MS at?

CirclFi does not provide target buy prices or price alerts. However, our 12 active models produce fair value estimates ranging from $8.36 to $440.36. At $215.50, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for MS.

View MS Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →